Clinical Trial Update: A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps [Phase 4]

View source ↗

Summary

Phase 4 real-world head-to-head trial in Danish patients compares dupilumab with mepolizumab for chronic rhinosinusitis with nasal polyps and asthma; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Eosinophilia
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• DUPIXENT (DUPILUMAB)
• Nucala (mepolizumab)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Chronic Rhinosinusitis With Nasal Polyps, Asthma; Eosinophilic | Phase 4 | Status: ACTIVE_NOT_RECRUITING